HBV
HBV inhibitors are compounds designed to target and inhibit various stages of the Hepatitis B virus (HBV) lifecycle. These inhibitors can interfere with viral replication, assembly, or release, thereby reducing the viral load and helping to manage chronic HBV infections. Research into HBV inhibitors is crucial for developing effective antiviral therapies to prevent liver disease and cancer associated with HBV. At CymitQuimica, we offer a range of HBV inhibitors to support your research in virology, antiviral drug development, and infectious disease management.
Products of "HBV"
Sort by
IR415
CAS:IR415 selectively interacts with Hepatitis B virus X protein (HBx, Kd = 2 nM) and blocks HBV-mediated RNAi suppression, reverses the inhibitory effect of HBxFormula:C13H14F2N4SPurity:99.05%Color and Shape:SolidMolecular weight:296.34Ref: TM-T11669
5mg46.00€10mg74.00€25mg135.00€50mg226.00€100mg335.00€200mg469.00€1mL*10mM (DMSO)49.00€Paederoside
CAS:Paederoside deters beetles, isolated from aphids, and inhibits tumor-promotion in Epstein-Barr virus.Formula:C18H22O11SPurity:97.81% - 99.90%Color and Shape:SolidMolecular weight:446.43Ref: TM-T3S0872
1mg48.00€5mg88.00€10mg128.00€25mg205.00€50mg303.00€100mg445.00€200mg655.00€1mL*10mM (DMSO)99.00€Bay 41-4109 (less active enantiomer)
CAS:Bay 41-4109 less active enantiomer shows less activity than Bay 41-4109. BAY 41-4109 is a potent HBV inhibitor (IC50: 53 nM).Formula:C18H13ClF3N3O2Purity:98%Color and Shape:SolidMolecular weight:395.76Isochlorogenic acid A
CAS:Isochlorogenic acid A (3,5-Dicaffeoylquinic acid), a natural phenolic acid, exhibits antioxidant and anti-inflammatory properties.Formula:C25H24O12Purity:97.49% - 99.53%Color and Shape:Grey To Yellow Crystalline SolidMolecular weight:516.45Lagociclovir
CAS:Lagociclovir (MIV-210), a nucleoside analogue antiviral, treats HBV by inhibiting its replication in liver cancer cells.Formula:C10H12FN5O3Purity:98.90% - 99%Color and Shape:SolidMolecular weight:269.23Tobevibart
CAS:Tobevibart, an IgG1-lambda humanized monoclonal antibody targeting the hepatitis B virus (HBV) surface envelope protein, exhibits antiviral activity [1].Purity:98%Color and Shape:LiquidCanocapavir
CAS:Canocapavir (ZM-H1505R) is an HBV coat protein modulator with antiviral activity for the treatment of hepatitis B virus.Formula:C27H21BrFN5O3Purity:98.4% - 98.40%Color and Shape:SolidMolecular weight:562.39HLA-A*02:01&B2M&HBV (FLLTRILTI) Tetramer Protein, Human, MHC (His & Avi)
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide.Color and Shape:Odour Lyophilized PowderLibevitug
Libevitug is a humanized IgG1λ2 antibody targeting HBV, with HumanIgG1lambda2, Isotype Control as its corresponding isotype control.Color and Shape:Odour LiquidCatalpol
CAS:Catalpol (Catalpinoside) is an iridoid glycoside with neuroprotective, anti-inflammatory, and anti-hepatitis virus effects.Formula:C15H22O10Purity:98.08% - 99.84%Color and Shape:PowderMolecular weight:362.33AB-161
CAS:AB-161 is an orally active destabilizer of HBV RNA and an inhibitor of PAPD5/7, primarily targeting the liver. It treats hepatitis B virus (HBV) infection by reducing hepatitis B surface antigen (HBsAg) levels, exhibiting an EC50 value of 2.2 nM for HBsAg. AB-161 is applicable in HBV infection research.Formula:C21H21F2N3O5Color and Shape:SolidMolecular weight:433.41Bifendate
CAS:Bifendate (Bifendatatum) is commonly used to treat the transaminase elevation that caused by viral hepatitis and drug-induced liver injury.Formula:C20H18O10Purity:99.72%Color and Shape:SolidMolecular weight:418.35Oleana-2,12-dien-28-oic acid
CAS:Oleana-2,12-dien-28-oic acid inhibits HBV, blocking HBsAg/HBeAg and DNA replication in HepG2.2.15, used in hepatitis B research.Formula:C30H46O2Purity:98%Color and Shape:SoildMolecular weight:438.69Burfiralimab
CAS:Burfiralimab (hzVSF-v13) is a monoclonal immunoglobulin (IgG4) directed against waveform proteins and can be used to study rheumatoid arthritis.Purity:90%Color and Shape:LiquidHBV-IN-48
CAS:HBV-IN-48, an HBV inhibitor, exhibits potent antiviral activity against HBV in HepDE19 cells, demonstrated by its EC 50 value of 0.005 μM. Additionally, it effectively reduces serum HBV DNA levels in mouse models of HBV infection.Formula:C22H15F4N3O3Color and Shape:SolidMolecular weight:445.37Osthole
CAS:Osthole (Osthol), a potential inhibitor of histamine H1 receptor, has been shown to stimulate osteoblast proliferation and differentiation.Formula:C15H16O3Purity:99.93% - 99.96%Color and Shape:Fine White PowderMolecular weight:244.29HBV-IN-40
HBV-IN-40 (Compound 11826096), with an IC50 of 0.7 µM, serves as a potent HBV inhibitor and exhibits antiviral activity [1].Formula:C29H55Cl4N11Purity:98%Color and Shape:SolidMolecular weight:699.63Entecavir
CAS:Entecavir (SQ34676), a guanosine analogue, treats chronic HBV; may cause hepatitis B flares, not clear liver injury.Formula:C12H15N5O3Purity:100% - 99.14%Color and Shape:White To Off-White/Yellow Crystalline PowderMolecular weight:277.28Ref: TM-T0085L
5mg50.00€10mg87.00€25mg116.00€50mg166.00€100mg283.00€200mg432.00€500mg697.00€1mL*10mM (DMSO)50.00€HBV-IN-41
CAS:HBV-IN-41 (compound 45) is a potent, orally active inhibitor of Hepatitis B Virus (HBV), exhibiting an EC50 value of 0.027μM [1].Formula:C18H19ClFN5O3Purity:98%Color and Shape:SolidMolecular weight:407.83Clevudine
CAS:Clevudine (Levovir) fights HBV, blocks viral DNA synthesis, and has a long half-life reducing relapse risk after treatment.Formula:C10H13FN2O5Purity:99.88% - 99.97%Color and Shape:SolidMolecular weight:260.22
